Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
63,858.96 +52.16 (+0.08%) CMC Crypto 200
1,327.95 +50.97 (+3.99%)
Vaxil Bio Ltd. (VXL.V)
TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
At close: 10:39AM EDT
Currency in CAD
Valuation measures4
| Market cap (intra-day) | 1.37M |
| Enterprise value | 360.79k |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 1.59 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -0.79 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -50.00% |
| S&P500 52-week change 3 | 22.38% |
| 52-week high 3 | 0.0350 |
| 52-week low 3 | 0.0100 |
| 50-day moving average 3 | 0.0146 |
| 200-day moving average 3 | 0.0159 |
Share statistics
| Avg vol (3-month) 3 | 64.49k |
| Avg vol (10-day) 3 | 49.15k |
| Shares outstanding 5 | 136.98M |
| Implied shares outstanding 6 | 136.98M |
| Float 8 | N/A |
| % held by insiders 1 | 8.16% |
| % held by institutions 1 | 0.02% |
| Shares short (15 Apr 2024) 4 | 15.9k |
| Short ratio (15 Apr 2024) 4 | 0.01 |
| Short % of float (15 Apr 2024) 4 | N/A |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.00% |
| Shares short (prior month 15 Mar 2024) 4 | 19.99k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:2 |
| Last split date 3 | 10 Mar 2016 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -12.61% |
| Return on equity (ttm) | -25.06% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -252k |
| Net income avi to common (ttm) | -254k |
| Diluted EPS (ttm) | -0.0100 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 938k |
| Total cash per share (mrq) | 0.01 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 11.48 |
| Book value per share (mrq) | 0.01 |
Cash flow statement
| Operating cash flow (ttm) | -561k |
| Levered free cash flow (ttm) | -465.75k |
© 2024 Yahoo. All rights reserved.